Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire

Company announcement – No. 19 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, May 29, 2026 –…

swissinfo.ch - Jessica Davis Plüss (text) Kai Reusser (visuals) - AI's next pharma challenge: tackling costly and risky clinical trials
AI's next pharma challenge: tackling costly and risky clinical trials
www.swissinfo.ch

Ask a pharmaceutical company about the current approach to clinical trials and you're likely to hear a chorus of complaints about a broken and dysfunctional system. It takes on average at least a decade and roughlyExternal link $1-2 billion (CHF790…

thedrinksbusiness.com - Amelie Maurice-Jones - South Korean pharma firm plots pivot into liquor
South Korean pharma firm plots pivot into liquor
The Drinks Business

From Suntory to BrewDog, a flurry of booze brands have leapt into the health sector in a bid to boost revenue. Now, in an uno-reverse, Korean pharmaceutical firm Kyung Nam Pharm, has reportedly set its sights on the spirits market. In recent times…

thehindubusinessline.com - Natco Pharma's Q4 net down 34% at ₹269 cr
Natco Pharma's Q4 net down 34% at ₹269 cr
BusinessLine

Natco Pharma's consolidated net profit declined 34 percent at ₹269 crore in the fourth quarter of last financial year ended March 31, 2026 compared to ₹406 crore in the corresponding quarter previous year. The total revenue of the…

wsj.com - Health Care Roundup: Market Talk
Health Care Roundup: Market Talk
Wall Street Journal

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0815 GMT – Bayer's pharmaceutical business has good momentum but faces risks over the medium term from…

marketbeat.com - United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Purchases Shares of 234,551 Royalty Pharma PLC $RPRX
MarketBeat

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund purchased a new stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most…

news-medical.net - Half of clinical trial professionals cite trust and regulatory gaps as barrier to AI adoption, Pistoia Alliance poll finds
Half of clinical trial professionals cite trust and regulatory gaps as barrier to AI adoption, Pistoia Alliance poll finds
News-Medical

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has released new poll data showing trust and regulatory uncertainty are the biggest barriers to AI adoption in clinical trials…

afr.com - Bonnie Campbell - Billionaire Dennis Bastas pays record $136.1m for Toorak mega estate
Billionaire Dennis Bastas pays record $136.1m for Toorak mega estate
Australian Financial Review

Pharma billionaire Dennis Bastas and his wife Gina paid a total of $136.1 million to create Australia's most expensive estate through a two-title deal that takes in both the landmark Toorak Italianate mansion Coonac and an adjoining 1950s apartment…

thehindubusinessline.com - Three companies receive SEBI'S nod to float IPOs
Three companies receive SEBI'S nod to float IPOs
BusinessLine

Rodec Pharma, Renny Strips, and Krishna Buildspace have secured SEBI's approval to raise funds t hrough initial public offerings (IPOs), an update with the markets regulator showed on Friday. Renny Strips Ltd, a steel structural products…

seekingalpha.com - Wall Street Breakfast - Wall Street Breakfast Podcast: New Glenn Ignites Concern
Wall Street Breakfast Podcast: New Glenn Ignites Concern
Seeking Alpha

Listen below or on the go via Apple Podcasts and Spotify Blue Origin's (BORGN) New Glenn rocket explodes on launchpad. (00:14) Tesla (TSLA) Robotaxi fleet in Texas is less than one-tenth of Waymo's. (01:03) Costco (COST) sees record fuel sales…

prnewswire.com - Kelun-Biotech - Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
Cision PR Newswire

The study enrolled 71 patients who had previously received platinum-based chemotherapy and immunotherapy (pre-treated patients) and 92 patients who had not received prior systemic therapy (treatment-naïve patients). As of the data cutoff date…

theguardian.com - Guardian staff reporter - She criticizes capitalism - and also gives investing advice: 'It's better to participate than working until we die'
She criticizes capitalism - and also gives investing advice: 'It's better to participate than working until we die'
The Guardian

Amanda Holden is, in her words, an “ex-finance bro”. She landed a job in investment management right out of college and was earning a six-figure income by her early 20s. But after five years of “letting grown men scream at me…

fool.com - Motley Fool Transcribing - Icon Public (ICLR) Q4 2025 Earnings Transcript
Icon Public (ICLR) Q4 2025 Earnings Transcript
The Motley Fool

Thursday, May 28, 2026, at 8 a.m. ET Chief Executive Officer — Barry Balfe Chief Financial Officer — Nigel Clerkin Head of Investor Relations — Kate Haven Accounting investigation and restatements -- Revenue restatements…

fool.com - Ben Gran - This Global ETF Beat the Nasdaq-100 for Most of the Past Year. Should You Buy It?
This Global ETF Beat the Nasdaq-100 for Most of the Past Year. Should You Buy It?
The Motley Fool

Usually, tech stocks are the best place to put your money, right? Not always. International dividend stocks have been strong lately. Until mid-April, the Vanguard International High Dividend Yield ETF (VYMI +0.40%) had outperformed the Invesco QQQ…

globalnews.ca - Staff - Quebec lawyers finding creative ways to reach potential opioid class-action members - Montreal
Quebec lawyers finding creative ways to reach potential opioid class-action members - Montreal
Global News

When Caroline Rivest broke her ankle a few years ago, a doctor prescribed her a powerful opioid for three months to help with the pain. She was hooked in no time. After her prescription ran out, she turned to the black market to keep the withdrawal…

Receive a Daily briefing on Pharma Industry News

Get Started